NCT04678232

Brief Summary

The R61 will be an open trial to determine if Positive Processes and Transition to Health (PATH) engages the proposed targets: unproductive processing, avoidance, and reward deficits in a sample of 45 adults who have experienced a destabilizing life event involving profound loss or threat, report persistent stressor-related symptoms of PTSD and/or depression, and are elevated on symptoms related to 2 of the 3 therapeutic targets. Additionally, will examine whether patients perceive PATH as helpful and complete/adhere to treatment, and therapist fidelity. Patients will receive 6 sessions of PATH (with 2 boosters, if partial responders). Primary targets will be assessed at pre-treatment, week 4, post-treatment, and at 1- and 3-month follow-up; secondary targets at pre-treatment, weekly during treatment, post-treatment, and at 1- and 3-month follow-ups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable major-depressive-disorder

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

October 30, 2024

Completed
Last Updated

October 30, 2024

Status Verified

October 1, 2024

Enrollment Period

1.7 years

First QC Date

December 8, 2020

Results QC Date

August 27, 2024

Last Update Submit

October 9, 2024

Conditions

Keywords

transdiagnostic interventionptsdposttraumatic stress disordermddmajor depressive disorderadulttherapymental healthdestabilizing life eventsstressful life events

Outcome Measures

Primary Outcomes (3)

  • Affective Updating Task (Pe et al., 2013; Pe, Raes, et al., 2013)

    The Affective Updating task (Pe et al., 2013; Pe, Raes, et al., 2013) measures updating of affective information in working memory. The task requires participants to continuously monitor and modify relevant affective information in working memory. Performance is inhibited by rumination. Forty-seven positive and 49 negative words are included. Under high levels of stress, deficits in affective updating predict more depressive symptoms over one year (Pe et al., 2016) and efficiency of reappraisal (Pe et al., 2013). Affective updating in contrast, predicts subjective well-being (Pe et al., 2013). The AUT is scored using the mean proportion of correct responses across 4 types of stimulus sets (positive-positive-positive words, negative-negative-negative, positive-negative-positive, negative-positive-negative). Scores for the AUT range from 0 to 1. Lower scores reflect greater deficits in affecting updating, while higher scores indicate greater abilities with affective updating.

    Score at 6 weeks (immediately post treatment)

  • Idiographic Behavioral Approach Task

    The Idiographic Behavioral Approach Task (BAT; Mori \& Aermendariz, 2001; Haynes, 2001) will use in vivo confrontation with feared or avoided stimuli measuring avoidance behavior. Each BAT is unique to each participant (e.g., news/videos of similar events, pictures of loved one). A general list of idiographic stimuli will be developed with participants, who will then approach the stimuli. The task requires participants to rate their subjective units of distress (SUDs) on a scale of 0-100 (0 = no distress, 100 = extreme distress). The primary outcome measured is mean peak SUDs. The mean peak SUDs is calculated by averaging together all of the participant's reported SUDs measured at their highest level of distress. Higher scores indicate a higher average level of distress across all items, and lower scores indicate less distress on average across all items.

    Score at 6 weeks (immediately post treatment)

  • Probabilistic Reward Task (Pizzagalli et al., 2005)

    The Probabilistic Reward Task (PRT) assesses reward responsivity (e.g., Der-Avakian et al. 2013; Pizzagalli et al., 2005, 2008, 2008). In each trial, participants choose which of 2 difficult-to-differentiate stimuli was presented. Stimuli are groups of bunnies or dogs (diameter: 25 mm; eyes: 7 mm). Unknown to them, correct identification of the "rich stimulus" is rewarded 3 times more frequently ("Correct! You won 20 cents"). Reward propensity is calculated by increase in response bias during the final block relative to the first. Degree of response bias toward the frequently reinforced alternative is a robust measure of reward sensitivity (Pizzagalli et al., 2005, 2008; Vrieze et al., 2013). The PRT is administered online through Inquisit Lab on Millisecond. PRT scores range between -.75 to .65 (-.75 = lower reward sensitivity, .65 = greater reward sensitivity).

    Score at 6 weeks (immediately post treatment)

Secondary Outcomes (3)

  • Posttraumatic Cognitions Inventory (Foa et al., 1999)

    Score at 6 weeks (immediately post treatment)

  • Behavioral Activation for Depression Scale (Kanter et al., 2006)

    Score at 6 weeks (immediately post treatment)

  • Snaith-Hamilton Pleasure Scale (Snaith et al., 1995)

    Score at 6 weeks (immediately post treatment)

Study Arms (1)

receive PATH therapy

EXPERIMENTAL

PATH includes six 60-90 min, weekly sessions, with two booster sessions for partial responders. Session 1 provides the PATH rationale and a review of life events (PATH of life: negative and positive). A rationale for an explicit focus on positive events/emotions will be provided. Sessions 2-4 focus on a verbal narrative of the destabilizing life event, reminiscence and processing of a major positive life event, and real-life practice to enact what was taught. Sessions 5 focuses on constructive processing and provides opportunity for integration and consolidation of learning. Session 6 focuses on future negative and positive events to promote application of new learning and resilience. Booster sessions focus on positive and negative life events since the last session and adaptive processes (constructive processing, approach, and reward). All sessions will include cultivation and elaboration of positive emotions to promote engagement and to build on the benefits of positive emotions.

Behavioral: Positive Processes and Transition to Health (PATH)

Interventions

See arm/group description for details regarding this intervention

Also known as: PATH
receive PATH therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Destabilizing life event involving profound loss or threat, with a minimum duration of 12 weeks since the event, but occurred within the last 5 years.
  • Between the ages of 18 and 65.
  • Elevated target: Scores of at least moderate (1 or higher) on at least 2 of the 3 target mechanisms: re- experiencing or ruminative processing of the destabilizing event (PSS-I items: 1, 2, 3, 4 or QIDS-C item 11), avoidance (PSS-I items 6, 7, 8), or reward deficits (PSS-I items 12, 13, or QIDS-C item 13).

You may not qualify if:

  • Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder as defined by DSM-5.
  • Current diagnosis of bipolar disorder, depression with psychotic features, or depression severe enough to require immediate psychiatric treatment (i.e., serious suicide risk with intent and plan).
  • Severe self-injurious behavior or suicide attempt within the previous three months.
  • Unwilling or unable to discontinue current cognitive behavioral psychotherapy.
  • No clear memory of the destabilizing event or event occurred before age 3.
  • Unstable dose of psychotropic medications in prior 3 months.
  • Ongoing intimate relationship with the perpetrator (in assault related event).
  • Current diagnosis of a substance use disorder (DSM-5).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Delaware

Newark, Delaware, 19716, United States

Location

Case Western Reserve University

Cleveland, Ohio, 44106, United States

Location

University of Washington

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Depressive Disorder, MajorStress Disorders, Post-TraumaticPsychological Well-Being

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersPersonal SatisfactionBehavior

Results Point of Contact

Title
Norah Feeny, PhD
Organization
Case Western Reserve University

Study Officials

  • Norah C Feeny, PhD

    Case Western Reserve University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants will receive PATH therapy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 8, 2020

First Posted

December 21, 2020

Study Start

October 1, 2021

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

October 30, 2024

Results First Posted

October 30, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations